𝔖 Bobbio Scriptorium
✦   LIBER   ✦

924 Long-Term Outcome Following Infliximab Therapy in Pediatric Patients with Crohn Disease: Results from a Multicenter Study

✍ Scribed by Jeffrey S. Hyams; Trudy Lerer; Marian D. Pfefferkorn; Subra Kugathasan; Jonathan Evans; Anthony R. Otley; Anne M. Griffiths; Ryan S. Carvalho; David R. Mack; Athos Bousvaros; Joel R. Rosh; Petar Mamula; M. Susan Moyer; Marsha H. Kay; Wallace Crandall; Maria Oliva-Hemker; David Keljo; Neal S. LeLeiko; James Markowitz

Book ID
119428498
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
218 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cancer in Crohn's Disease patients treat
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study
✍ Livia Biancone; Carmelina Petruzziello; Ambrogio Orlando; Anna Kohn; Sandro Ardi πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 171 KB πŸ‘ 2 views

## Background: The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term. Methods: A multic

Long-term outcome of treatment with infl
Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study
✍ ValΓ©rie CrombΓ©; Julia Salleron; Guillaume Savoye; Jean-Louis Dupas; GwΓ©nola Vern πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 549 KB

Background: We examined short-and long-term benefits and safety of infliximab (IFX) in a population-based cohort of Crohn's disease (CD) patients <17 years old at diagnosis. ## Methods: The following parameters were assessed: short-and long-term efficacy of IFX, impact of drug efficacy, and mode